In numerous cancers, among them melanoma, non-small cell lung cancer (NSCLC), ovarian cancer, gastric cancer, and colorectal cancer, high CXCL9/CXCL10 levels indicate favorable prognosis, and low levels indicate poor prognosis (13–19). This evidence concerns the gene CXCL10 and colorectal cancer.